Benzinga··Vandana SinghIDEXX Lifts 2026 Outlook as Pet Diagnostic Demand Accelerates
IDEXX Laboratories beats Q1 expectations and raises full-year guidance, citing stronger clinical visits and diagnostic frequency across its pet healthcare segment.
IDXXearnings beatorganic growth